Paper41394271
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.
Jackson JW and 13 others. Mol Ther Oncol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. Papers, record 41394271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41394271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28214226 | CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. | Immunity | 2017 | https://conductscience.org/library/papers/28214226 | PubMed |
| 2 | 31237234 | Circulating T cell-monocyte complexes are markers of immune perturbations. | Elife | 2019 | https://conductscience.org/library/papers/31237234 | PubMed |
| 3 | 31787969 | CD3+ Macrophages Deliver Proinflammatory Cytokines by a CD3- and Transmembrane TNF-Dependent Pathway and Are Increased at the BCG-Infection Site. | Front Immunol | 2019 | https://conductscience.org/library/papers/31787969 | PubMed |
| 4 | 10681459 | Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10681459 | PubMed |
| 5 | 34372501 | Oncolytic Viruses for Malignant Glioma: On the Verge of Success? | Viruses | 2021 | https://conductscience.org/library/papers/34372501 | PubMed |
| 6 | 23754388 | Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23754388 | PubMed |
| 7 | 33782623 | Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. | Nat Neurosci | 2021 | https://conductscience.org/library/papers/33782623 | PubMed |
| 8 | 36700223 | Pre-clinical models for evaluating glioma targeted immunotherapies. | Front Immunol | 2022 | https://conductscience.org/library/papers/36700223 | PubMed |
| 9 | 29262845 | Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. | Genome Biol | 2017 | https://conductscience.org/library/papers/29262845 | PubMed |
| 10 | 16053696 | Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model. | Neuro Oncol | 2005 | https://conductscience.org/library/papers/16053696 | PubMed |
| 11 | 30080893 | A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/30080893 | PubMed |
| 12 | 31792954 | The IFITM protein family in adaptive immunity. | Immunology | 2020 | https://conductscience.org/library/papers/31792954 | PubMed |
| 13 | 33524948 | Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas. | Neurosurg Focus | 2021 | https://conductscience.org/library/papers/33524948 | PubMed |
| 14 | 35798133 | Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis. | J Hepatol | 2022 | https://conductscience.org/library/papers/35798133 | PubMed |
| 15 | 33178203 | Localized Interleukin-12 for Cancer Immunotherapy. | Front Immunol | 2020 | https://conductscience.org/library/papers/33178203 | PubMed |
| 16 | 25658639 | Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. | PLoS One | 2015 | https://conductscience.org/library/papers/25658639 | PubMed |
| 17 | 27314913 | Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma. | Hum Gene Ther Clin Dev | 2016 | https://conductscience.org/library/papers/27314913 | PubMed |
| 18 | 29123084 | Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent. | Nat Commun | 2017 | https://conductscience.org/library/papers/29123084 | PubMed |
| 19 | 9574551 | In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. | J Immunol | 1998 | https://conductscience.org/library/papers/9574551 | PubMed |
| 20 | 35705536 | Ly6D+Siglec-H+ precursors contribute to conventional dendritic cells via a Zbtb46+Ly6D+ intermediary stage. | Nat Commun | 2022 | https://conductscience.org/library/papers/35705536 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42193877 | Reprogramming the Immunosuppressive Microenvironment in Glioblastoma Through Oncolytic Herpes Simplex Virus Therapy: A Systematic Review. | Cells | 2026 | https://conductscience.org/library/papers/42193877 | PubMed |
| 41951817 | Tumour trap: engineered enhancer sequences enlisted to kill cancer cells. | Nature | 2026 | https://conductscience.org/library/papers/41951817 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41394271
GET https://conductscience.org/api/papers/v1/41394271/references?page=2